Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.

MLA

Volckmar, Anna-Lena, et al. “Combined Targeted DNA and RNA Sequencing of Advanced NSCLC in Routine Molecular Diagnostics: Analysis of the First 3,000 Heidelberg Cases.” International Journal of Cancer, vol. 145, no. 3, Aug. 2019, pp. 649–61. EBSCOhost, https://doi.org/10.1002/ijc.32133.

APA

Volckmar, A.-L., Leichsenring, J., Kirchner, M., Christopoulos, P., Neumann, O., Budczies, J., Morais de Oliveira, C. M., Rempel, E., Buchhalter, I., Brandt, R., Allgäuer, M., Talla, S. B., von Winterfeld, M., Herpel, E., Goeppert, B., Lier, A., Winter, H., Brummer, T., Fröhling, S., … Stenzinger, A. (2019). Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases. International Journal of Cancer, 145(3), 649–661. https://doi.org/10.1002/ijc.32133

Chicago

Volckmar, Anna-Lena, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, et al. 2019. “Combined Targeted DNA and RNA Sequencing of Advanced NSCLC in Routine Molecular Diagnostics: Analysis of the First 3,000 Heidelberg Cases.” International Journal of Cancer 145 (3): 649–61. doi:10.1002/ijc.32133.